Frost & Sullivan have completed a study entitled “Targeted Use of Complementary Medicines: Potential  Health Outcomes and Cost Savings in Australia”

”The objective of this report is to determine the potential net economic savings that could be realised given the usage of CM that are scientifically shown to reduce the occurrence of disease-related events among targeted populations. Specifically, this report will attempt to show that the use of specific CM can result in health care cost savings by preventing costly disease-related events.”

For full report click here.

For summary of results click here.